# CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry

> **NCT06804057** · — · RECRUITING · sponsor: **CorEvitas** · enrollment: 1000 (estimated)

## Conditions studied

- Systemic Lupus Erythematosus

## Interventions

- **OTHER:** Blood Collection

## Key facts

- **NCT ID:** NCT06804057
- **Lead sponsor:** CorEvitas
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-26
- **Primary completion:** 2099-12-31
- **Final completion:** 2099-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06804057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06804057, "CorEvitas Systemic Lupus Erythematosus (SLE) Drug Safety and Effectiveness Registry". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06804057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*